Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
RISPERDAL
Generic name / active ingredient
risperidone
Dosage-form class
RISPERDAL risperidone regular oral tablets: current product-identity and supply information lists 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. The 0.25 mg figure appears only in dosing text and is not a current regular-tablet package strength. Oral solution and M-TAB orally disintegrating tablets are not merged into this dossier.
Route
Oral
Record reviewed
2026-08-28

Copy from the pack in hand

Source-linked reading points

  • Check brand, risperidone, actual dosage form, labelled amount per unit, NDC, pack and target market together. Current product-identity and supply information lists only five regular-tablet 60-count bottles: 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. A 0.25 mg figure in dosing text is not a sixth current regular-tablet package. Regular tablets, oral solution and M-TAB orally disintegrating tablets are also not presentations that a webpage can self-convert by milligrams, tablet count or appearance.
  • The U.S. label has a boxed warning for elderly patients with dementia-related psychosis and states that RISPERDAL is not approved for that population. This is a reading and prompt-professional-review cue, not a webpage diagnosis, prescription, stopping or care decision for anyone. With older age, cognitive change, falls, fainting, unusual drowsiness or multiple medicines, have the local care team review every actual pack.
  • Do not self-combine, alternate on different days, change an oral product to a long-acting injection or borrow a family member's medicine because products all say risperidone, relate to mental health, or may affect sleep or behaviour. Take prescription medicines, OTC products, supplements and actual packs to a pharmacist or prescribing team for item-by-item review.
  • With breathing difficulty, swelling of the face or tongue, fainting, inability to wake, fever with muscle rigidity, chest discomfort, a marked rhythm concern, a serious fall or another acute serious concern, prioritise local emergency medical support; do not wait for a website search or self-counteract with another medicine.

Reviewed presentation examples — compare every field

  • Risperidone 0.5 mg per tablet; 60-tablet bottle (NDC 50458-302-06)NDC 50458-302-06
  • Risperidone 1 mg per tablet; 60-tablet bottle (NDC 50458-300-06)NDC 50458-300-06
  • Risperidone 2 mg per tablet; 60-tablet bottle (NDC 50458-320-06)NDC 50458-320-06
  • Risperidone 3 mg per tablet; 60-tablet bottle (NDC 50458-330-06)NDC 50458-330-06
  • Risperidone 4 mg per tablet; 60-tablet bottle (NDC 50458-350-06)NDC 50458-350-06

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-28
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image